Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 54573-75-0
- Molecular formula
- C28H44O2
- Molecular weight
- 412.6 g/mol
- Drug class
- Vitamin D2 Analog
- Mechanism of action
- Doxercalciferol is a synthetic vitamin D 2 analog that requires metabolic activation to form the active 1α,25-(OH) 2 D 2 metabolite, which binds to the vitamin D receptor (VDR) to result in the selective activation of vitamin D responsive pathways.
- Indications / reported uses
- Hyperparathyroidism
- secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with CKD on dialysis
- secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) on dialysis
- secondary hyperparathyroidism in adult patients with CKD on dialysis
Identification source: PubChem record (CID 5281107). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.